Treatment of patients with hereditary angioedema with normal C1 inhibitor and without F12 gene mutations (HAE-unknown)

被引:0
|
作者
Bork, K. [1 ]
Witzke, G. [1 ]
Wulff, K. [2 ]
Hardt, J. [3 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dermatol, Mainz, Germany
[2] Univ Med Greifswald, Greifswald, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Med Psychol & Med Sociol, Mainz, Germany
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
174
引用
收藏
页码:87 / 87
页数:1
相关论文
共 50 条
  • [41] CLINICAL PROFILE AND TREATMENT OUTCOMES IN PATIENTS WITH HEREDITARY ANGIOEDEMA WITH NORMAL C1 ESTERASE INHIBITOR
    Jones, D.
    Bansal, P.
    Bernstein, J.
    Fatteh, S.
    Harper, J.
    Hsu, F.
    Jain, S.
    O'Connor, M.
    Park, N.
    Wilson, B.
    Zacek, L.
    Suez, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S31 - S32
  • [42] Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor
    Jones, Douglas H.
    Bansal, Priya
    Bernstein, Jonathan A.
    Fatteh, Shahnaz
    Harper, Joseph
    Hsu, F. Ida
    O'Connor, Maeve
    Park, Nami
    Suez, Daniel
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (01):
  • [43] sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor
    Larrauri, Blas
    Hester, C. Garren
    Jiang, Haixiang
    Miletic, Vojislav D.
    Malbran, Alejandro
    Bork, Konrad
    Kaplan, Allen
    Frank, Michael
    MOLECULAR IMMUNOLOGY, 2020, 119 : 27 - 34
  • [44] Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor
    Dewald, G
    Bork, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (04) : 1286 - 1289
  • [45] The effect of tranexamic acid on disease control in hereditary angioedema with normal C1 inhibitor (type III HAE)
    Tuncay, G.
    Bostan, O. Can
    Kayikci, H.
    Cihanbeylerden, M.
    Damadoglu, E.
    Soyer, O. Uysal
    Birben, E.
    Karakaya, G.
    Kalyoncu, A. F.
    ALLERGY, 2023, 78
  • [46] DETECTION OF POINT MUTATIONS OF THE C1 INHIBITOR GENE IN PATIENTS WITH TYPE-I HEREDITARY ANGIOEDEMA
    ZURAW, BL
    HERSCHBACH, J
    FASEB JOURNAL, 1994, 8 (05): : A766 - A766
  • [47] A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema (HAE)
    van Doorn, MBA
    Nuijens, J
    van Dam, T
    Levi, M
    Hack, E
    Cohen, AF
    Burggraaf, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 136 - 136
  • [48] Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
    McKibbin, Lundy
    Barber, Colin
    Kalicinsky, Chrystyna
    Warrington, Richard
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (01):
  • [49] Mutations analysis of C1 inhibitor coding sequence gene among Portuguese patients with hereditary angioedema
    Martinho, A.
    Mendes, J.
    Simoes, O.
    Nunes, A.
    Gomes, J.
    Dias Castro, E.
    Leiria-Pinto, P.
    Ferreira, M. B.
    Pereira, C.
    Castel-Branco, M. G.
    Pais, L.
    MOLECULAR IMMUNOLOGY, 2013, 53 (04) : 431 - 434
  • [50] Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
    Lundy McKibbin
    Colin Barber
    Chrystyna Kalicinsky
    Richard Warrington
    Allergy, Asthma & Clinical Immunology, 15